VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) shot up 58.8% during mid-day trading on Thursday . The company traded as high as C$0.15 and last traded at C$0.14. 2,646,987 shares were traded during trading, an increase of 1,242% from the average session volume of 197,312 shares. The stock had previously closed at C$0.09.
VentriPoint Diagnostics Trading Down 23.3 %
The business has a 50 day simple moving average of C$0.10 and a 200-day simple moving average of C$0.13. The company has a debt-to-equity ratio of -58.56, a quick ratio of 6.67 and a current ratio of 0.28. The stock has a market capitalization of C$18.65 million, a P/E ratio of -3.55 and a beta of 0.39.
VentriPoint Diagnostics Company Profile
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
Featured Articles
- Five stocks we like better than VentriPoint Diagnostics
- What is the Hang Seng index?
- Autodesk Designs Value for Investors: Uptrend Set to Continue
- The 3 Best Blue-Chip Stocks to Buy Now
- Anheuser-Busch Stock Rallies—Is the King of Beers Back?
- How to Effectively Use the MarketBeat Ratings Screener
- MarketBeat Week in Review – 02/24 – 02/28
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
